Based on these deductions, we here knock down five additional genes related to iron and redox homeostasis (NRF2, GPX4, SLC7A11, FSP1, FTH1) [28, 30, 34–36], for further improving the anti-tumor efficacy of GIFT. The gene discussed is SLC7A11; the disease is neoplasm.